Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Komipharm International Co Ltd

041960.KQ ✓ COMPLIANT ☆ Track — members

KOSDAQ · Healthcare · Pharmaceuticals ·

South Korea Small Cap Analyst: N/A

Last Close

$6.49

▲ +0.55%

Market Cap $479.40M · Vol 158.95K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$479.40M

Small Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

82.22

Momentum

Beta

0.20

vs Market

52W High

$7.62

11.71% below

52W Low

$3.71

72.90% above

Volume

158.95K

Avg 201.72K

P/B

7.26

Price-to-book

ROE

N/A

Return on equity

Free Float

60.73%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Komipharm International Co Ltd (041960.KQ) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does 041960.KQ pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+10.58%

+31.99%

+6.60%

-3.66%

YTD

+31.05%

+63.70%

+51.45%

-10.39%

Financials & Valuation

TTM · Annual

Total Revenue	$36.42M
Net Income	$-5,572,902.00
Revenue Growth (YoY)	+22.11%
Gross Margin	32.51%
Operating Margin	3.74%
Net Profit Margin	-15.30%
ROE	N/A
ROA · ROIC	-6.18% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	9.46
P/B	7.26
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	73.89M

Technical Indicators

50-Day SMA	$5.49
200-Day SMA	$5.45
RSI (14)	82.22
Beta	0.20
52-Week High	$7.62
52-Week Low	$3.71

Volume Today	158.95K
Avg Daily Volume (30D)	201.72K
Relative Volume	0.79x
Volatility (10D)	52.44
Volatility (30D)	58.38
Free Float	60.73%

Analyst Consensus

N/A

Current Price $6.49

Mean Target N/A

52W Low$3.71 52W High$7.62

Current

Target

$3.71 $7.62

Current Analyst target

· 0 analysts

Identifiers

ExchangeKOSDAQ

FIGIBBG001S9FM84

ISINKR7041960006

CountryKorea; Republic (S. Korea)

Sub-IndustryVeterinary Drugs

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ZTS Zoetis Inc -2.70% ELAN Elanco Animal Health Inc +5.15% 600299.SS Bluestar Adisseo Co -0.48% VIRP.PA Virbac SA +0.30% 600201.SS Jinyu Bio-Technology Co Ltd -0.81%

Company Profile

Komipharm International Co Ltd is a Korea-based company principally engaged in the development and manufacture of veterinary vaccines and veterinary pharmaceuticals. The Company’s main products include veterinary vaccines such as total vaccines of respiratory disease for swine, vaccines of anthrax disease and black leg for cattle, vaccines for infectious bronchitis and Newcastle disease, and canine respiratory infection killed vaccines, and veterinary pharmaceuticals such as antibiotics, nutrients, disinfectants and others, which are used to treat pneumonia, pasteurellosis, enteritis, mastitis, swine erysipelas, septicemia, leptospirosis and bacterial diseases for livestock. The Company also engages in research and development of anticancer drugs and cancer pain-relieving agents. In addition, the Company provides services such as pathological biopsies, serum tests, and bacteria tests.